Myocardial infarction, commonly known as a heart attack, occurs when blood flow decreases or stops to part of the heart, causing damage to the heart muscle. It is a life-threatening medical condition that requires immediate medical attention to minimize damage to the heart. Various products are available for the diagnosis and treatment of myocardial infarction like ECG devices, cardiac imaging equipment, cardiac biomarkers tests, and others.

The global myocardial infarction market is estimated to be valued at US$ 1,816.8 Mn in 2021, and is expected to exhibit a CAGR of 5.9 % over the forecast period (2021-2028).

Myocardial Infarction Market Demand is growing prevalence of cardiovascular diseases and increasing healthcare expenditure in emerging economies present significant growth opportunities in the myocardial infarction diagnostics market. According to WHO, cardiovascular diseases account for over 17 million deaths annually, with myocardial infarction being a major type. This growing disease burden is expected to drive the demand for accurate diagnostics.

Get More Insights – Myocardinal Infarction Market